Telcare Raises $25.5M in Series B Equity Funding
Telcare, Inc., a Bethesda, MD-based developer of a wireless glucose monitoring system for people with diabetes, has raised $25.5m in Series B equity funding.
The round was led by Sequoia Capital, with participation from existing investor, Qualcomm Inc., acting through its Qualcomm Life Fund.
The company intends to use the capital for marketing and sales efforts, research and development initiatives, and ongoing operations.
Founded in 2008 by David Bjork, John R. Dwyer, Jr., Chairman, and Jonathan C. Javitt, M.D., M.P.H., CEO and Vice Chairman, Telcare provides a comprehensive diabetes solution consisting of a wireless glucose meter with two-way messaging that transmits to an FDA-cleared care management server, along with a suite of iPhone and Android apps to enable family members to follow the progress of loved ones with diabetes.